Pulmonary insufficiency is the main cause of death in cystic fibrosis (CF). We analysed forced expiratory volume in 1 s (FEV1) data of 14 732 patients registered in the European Cystic Fibrosis Society Patient Registry (ECFSPR) database in 2007. We used linear and logistic regressions to investigate associations between FEV1 % predicted and clinical outcomes. Body mass index (BMI), chronic infection by Pseudomonas aeruginosa, pancreatic status and CF-related diabetes (CFRD) showed a statistically significant (all p<0.0001) and clinically relevant effect on FEV1 % pred after adjusting for age. Patients with a lower BMI experience a six-fold increased odds ratio (95% CI 5.0-7.3) of having severe lung disease (FEV1 <40% pred) compared to pati...
AbstractBackgroundThe goal of this study was to determine the association of multiple antibiotic-res...
RATIONAL: People with cystic fibrosis carrying residual function (RF) mutations are considered to ha...
FEV1 decline in cystic fibrosis I read the paper by Taylor-Robinson et al1 with interest with regard...
SummaryObstructive lung disease is the major cause of morbidity and mortality in cystic fibrosis (CF...
Aim To examine the trajectory of forced expiratory volume in 1 s (FEV1) using data from the European...
A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in th...
BackgroundForced expiratory volume in 1 s as a percentage of predicted (%FEV1) is a key outcome in c...
BackgroundCystic fibrosis (CF) is one of the most common recessively inherited disorders diagnosed i...
AbstractBackgroundPreviously we assessed risk factors for FEV1 decline in children and adolescents u...
To identify potential risk factors for lung disease progression in children with cystic fibrosis (CF...
Objective To evaluate the effect of allergic bronchopulmonary aspergillosis (ABPA) on FEV1 percent p...
Summary. Background: Patients with cystic fibrosis (CF) frequently experience pulmonary exacerbation...
Summary. The severity of lung disease in cystic fibrosis (CF) may be related to the type of mutation...
Background: Iron deficiency (ID) is common in patients with cystic fibrosis (CF) and may be related ...
Objective: Risk factors were investigated to find associations with oral antibiotic failure in cysti...
AbstractBackgroundThe goal of this study was to determine the association of multiple antibiotic-res...
RATIONAL: People with cystic fibrosis carrying residual function (RF) mutations are considered to ha...
FEV1 decline in cystic fibrosis I read the paper by Taylor-Robinson et al1 with interest with regard...
SummaryObstructive lung disease is the major cause of morbidity and mortality in cystic fibrosis (CF...
Aim To examine the trajectory of forced expiratory volume in 1 s (FEV1) using data from the European...
A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in th...
BackgroundForced expiratory volume in 1 s as a percentage of predicted (%FEV1) is a key outcome in c...
BackgroundCystic fibrosis (CF) is one of the most common recessively inherited disorders diagnosed i...
AbstractBackgroundPreviously we assessed risk factors for FEV1 decline in children and adolescents u...
To identify potential risk factors for lung disease progression in children with cystic fibrosis (CF...
Objective To evaluate the effect of allergic bronchopulmonary aspergillosis (ABPA) on FEV1 percent p...
Summary. Background: Patients with cystic fibrosis (CF) frequently experience pulmonary exacerbation...
Summary. The severity of lung disease in cystic fibrosis (CF) may be related to the type of mutation...
Background: Iron deficiency (ID) is common in patients with cystic fibrosis (CF) and may be related ...
Objective: Risk factors were investigated to find associations with oral antibiotic failure in cysti...
AbstractBackgroundThe goal of this study was to determine the association of multiple antibiotic-res...
RATIONAL: People with cystic fibrosis carrying residual function (RF) mutations are considered to ha...
FEV1 decline in cystic fibrosis I read the paper by Taylor-Robinson et al1 with interest with regard...